BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 15541657)

  • 21. Post-translational modifications regulate distinct functions of CARMA1 and BCL10.
    Thome M; Weil R
    Trends Immunol; 2007 Jun; 28(6):281-8. PubMed ID: 17468049
    [TBL] [Abstract][Full Text] [Related]  

  • 22. MALT lymphoma with t(14;18)(q32;q21)/IGH-MALT1 is characterized by strong cytoplasmic MALT1 and BCL10 expression.
    Ye H; Gong L; Liu H; Hamoudi RA; Shirali S; Ho L; Chott A; Streubel B; Siebert R; Gesk S; Martin-Subero JI; Radford JA; Banerjee S; Nicholson AG; Ranaldi R; Remstein ED; Gao Z; Zheng J; Isaacson PG; Dogan A; Du MQ
    J Pathol; 2005 Feb; 205(3):293-301. PubMed ID: 15682443
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Role of the CARMA1/BCL10/MALT1 complex in lymphoid malignancies.
    Juilland M; Thome M
    Curr Opin Hematol; 2016 Jul; 23(4):402-9. PubMed ID: 27135977
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Molecular pathways: targeting MALT1 paracaspase activity in lymphoma.
    Fontán L; Melnick A
    Clin Cancer Res; 2013 Dec; 19(24):6662-8. PubMed ID: 24004675
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Interplay between BCL10, MALT1 and IkappaBalpha during T-cell-receptor-mediated NFkappaB activation.
    Carvalho G; Le Guelte A; Demian C; Vazquez A; Gavard J; Bidère N
    J Cell Sci; 2010 Jul; 123(Pt 14):2375-80. PubMed ID: 20551178
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Negative feedback loop in T cell activation through IkappaB kinase-induced phosphorylation and degradation of Bcl10.
    Lobry C; Lopez T; Israël A; Weil R
    Proc Natl Acad Sci U S A; 2007 Jan; 104(3):908-13. PubMed ID: 17213322
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Structural architecture of the CARMA1/Bcl10/MALT1 signalosome: nucleation-induced filamentous assembly.
    Qiao Q; Yang C; Zheng C; Fontán L; David L; Yu X; Bracken C; Rosen M; Melnick A; Egelman EH; Wu H
    Mol Cell; 2013 Sep; 51(6):766-79. PubMed ID: 24074955
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Striking back at the activator: how IkappaB kinase terminates antigen receptor responses.
    Hinz M; Scheidereit C
    Sci STKE; 2007 May; 2007(384):pe19. PubMed ID: 17473308
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ca2+/calmodulin-dependent protein kinase II is a modulator of CARMA1-mediated NF-kappaB activation.
    Ishiguro K; Green T; Rapley J; Wachtel H; Giallourakis C; Landry A; Cao Z; Lu N; Takafumi A; Goto H; Daly MJ; Xavier RJ
    Mol Cell Biol; 2006 Jul; 26(14):5497-508. PubMed ID: 16809782
    [TBL] [Abstract][Full Text] [Related]  

  • 30. CARMA1, BCL-10 and MALT1 in lymphocyte development and activation.
    Thome M
    Nat Rev Immunol; 2004 May; 4(5):348-59. PubMed ID: 15122200
    [No Abstract]   [Full Text] [Related]  

  • 31. Molecular Determinants of Scaffold-induced Linear Ubiquitinylation of B Cell Lymphoma/Leukemia 10 (Bcl10) during T Cell Receptor and Oncogenic Caspase Recruitment Domain-containing Protein 11 (CARD11) Signaling.
    Yang YK; Yang C; Chan W; Wang Z; Deibel KE; Pomerantz JL
    J Biol Chem; 2016 Dec; 291(50):25921-25936. PubMed ID: 27777308
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Casein kinase 1alpha governs antigen-receptor-induced NF-kappaB activation and human lymphoma cell survival.
    Bidère N; Ngo VN; Lee J; Collins C; Zheng L; Wan F; Davis RE; Lenz G; Anderson DE; Arnoult D; Vazquez A; Sakai K; Zhang J; Meng Z; Veenstra TD; Staudt LM; Lenardo MJ
    Nature; 2009 Mar; 458(7234):92-6. PubMed ID: 19118383
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lymphocyte signaling and activation by the CARMA1-BCL10-MALT1 signalosome.
    Meininger I; Krappmann D
    Biol Chem; 2016 Dec; 397(12):1315-1333. PubMed ID: 27420898
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Potential role of CARMA1 in CD40-induced splenic B cell proliferation and marginal zone B cell maturation.
    Pappu BP; Lin X
    Eur J Immunol; 2006 Nov; 36(11):3033-43. PubMed ID: 17048267
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ubiquitination for activation: new directions in the NF-kappaB roadmap.
    Lynch OT; Gadina M
    Mol Interv; 2004 Jun; 4(3):144-6. PubMed ID: 15210867
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Deciphering the pathway from the TCR to NF-kappaB.
    Weil R; Israël A
    Cell Death Differ; 2006 May; 13(5):826-33. PubMed ID: 16439988
    [TBL] [Abstract][Full Text] [Related]  

  • 37. T cell receptor-dependent activation of mTOR signaling in T cells is mediated by Carma1 and MALT1, but not Bcl10.
    Hamilton KS; Phong B; Corey C; Cheng J; Gorentla B; Zhong X; Shiva S; Kane LP
    Sci Signal; 2014 Jun; 7(329):ra55. PubMed ID: 24917592
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Assembly mechanism of the CARMA1-BCL10-MALT1-TRAF6 signalosome.
    David L; Li Y; Ma J; Garner E; Zhang X; Wu H
    Proc Natl Acad Sci U S A; 2018 Feb; 115(7):1499-1504. PubMed ID: 29382759
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Regulation of NF-kappaB-dependent lymphocyte activation and development by paracaspase.
    Ruefli-Brasse AA; French DM; Dixit VM
    Science; 2003 Nov; 302(5650):1581-4. PubMed ID: 14576442
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Essential role for IkappaB kinase beta in remodeling Carma1-Bcl10-Malt1 complexes upon T cell activation.
    Wegener E; Oeckinghaus A; Papadopoulou N; Lavitas L; Schmidt-Supprian M; Ferch U; Mak TW; Ruland J; Heissmeyer V; Krappmann D
    Mol Cell; 2006 Jul; 23(1):13-23. PubMed ID: 16818229
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.